Barriers to universal prenatal HIV testing in 4 US locations in 1997

American Journal of Public Health
R A RoycePerinatal Guidelines Evaluation Project

Abstract

We determined rates of prenatal HIV testing and investigated barriers to testing. We surveyed 1362 representative parturient women from 7 hospitals in 4 locations of the United States. Overall, 89.9% of women reported being offered HIV testing and 69.6% reported being tested. Proportions of women not offered testing differed by location (range = 5.2%-16.3%), as did proportions not tested (range = 12.2%-54.4%). Among women who perceived that their clinicians had not recommended testing, 41.7% were tested, compared with 92.8% of women who perceived a strong recommendation (P < .05). Private insurance for prenatal care was also associated with not being tested. Women gave multiple reasons for not being tested, most commonly not being at risk, having been tested recently, and the test's not being offered or recommended, cited by 55.3%, 39.1% and 11.1% of women, respectively. Although most parturient women were offered a prenatal HIV test and got tested, testing proportions did not reach national goals and differed significantly by location and payment status. Concern about testing consequences was not a major barrier. Perception of clinicians' recommendations strongly influenced testing. Changing provider practices will be essentia...Continue Reading

References

Mar 23, 1991·Lancet·M BarbacciR E Chaisson
Nov 1, 1994·International Journal of STD & AIDS·J Meadows, J Catalan
Nov 1, 1993·Sexually Transmitted Diseases·J L JonesR A Gunn
Jan 1, 1997·Journal of Clinical Epidemiology·P O'CampoM Barbacci
Feb 1, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·K A PhillipsT Bleecker
Jun 1, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·C LimataC P Quesenberry
Apr 16, 1998·Obstetrics and Gynecology·D CarusiS F Posner
Apr 1, 1999·The New England Journal of Medicine·UNKNOWN International Perinatal HIV GroupR Tuomala
Apr 1, 1999·The New England Journal of Medicine·L E Riley, M F Greene
Oct 8, 1999·American Journal of Public Health·T E Wilson, H Minkoff
Mar 7, 2000·JAMA : the Journal of the American Medical Association·R NduatiJ Kreiss

❮ Previous
Next ❯

Citations

Dec 18, 2001·Prenatal Diagnosis
Jun 6, 2006·Maternal and Child Health Journal·Jill ClarkAmy Zapata
Mar 7, 2007·Maternal and Child Health Journal·Amy LanskyTonya Stancil
Oct 31, 2007·Maternal and Child Health Journal·Mayris P WebberMarc Bulterys
Jan 12, 2010·Maternal and Child Health Journal·Kathrine R TanDenise J Jamieson
Feb 9, 2011·Maternal and Child Health Journal·Pamela Rothpletz-PugliaDeanne Samuels
Sep 11, 2002·Obstetrics and Gynecology·Karen TroccoliJay Schulkin
Oct 29, 2002·Lancet·Sten H Vermund, Craig M Wilson
Oct 2, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·S L OrloffUNKNOWN Perinatal AIDS Collaborative Transmission Study
Jan 27, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Achara TeeraratkulUNKNOWN Bangkok Collaborative Perinatal HIV Transmission Study Group
Jan 30, 2013·Journal of Public Health Management and Practice : JPHMP·Darryl G KongJennifer Flood
Jan 17, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sheryl B LyssRobert A Weinstein
Jul 3, 2002·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Juan D RuizPaola Grasso
Oct 28, 2006·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Rhonda Y KroppYvonne A Maldonado
Feb 28, 2002·American Journal of Public Health·Joseph N Inungu
Feb 28, 2002·American Journal of Public Health·Linda J KoenigUNKNOWN Perinatal Guidelines Evaluation Project Group
Dec 3, 2014·Obstetrics and Gynecology Clinics of North America·Meghan Donnelly, Jill K Davies
Dec 24, 2002·The American Journal of the Medical Sciences·Stacy A NicholsSten H Vermund
Mar 28, 2009·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Debra J JacksonMickey Chopra
May 7, 2008·The Journal of the Association of Nurses in AIDS Care : JANAC·Robin HardwickeRichard M Grimes
Apr 28, 2007·Seminars in Perinatology·Elijah Paintsil, Warren A Andiman
Oct 23, 2009·American Journal of Obstetrics and Gynecology·Christopher V AlmarioJason K Baxter
Apr 4, 2006·Revista de saúde pública·Humberto RosaAndrew Tomkins
Oct 4, 2008·Revista de saúde pública·Valdiléa G VelosoFrancisco I Bastos
Apr 26, 2011·International Journal of STD & AIDS·M R KennedyH C Wiesenfeld
Jan 6, 2004·Obstetrics and Gynecology·John E AndersonStephanie Sansom

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.